ARROWHEAD PHARMACEUTICALS, INC. 10-K filing
Filed 2025-11-25 · Report date 2025-09-30 · 2025 FY
Filing metadata
- Accession number
- 0000879407-25-000029
- Form type
- 10-K
- CIK
- 0000879407
- Primary document
- https://www.sec.gov/Archives/edgar/data/879407/000087940725000029/arwr-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ARROWHEAD PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $829.4M | - | - |
| Operating Income | $98.3M | - | - |
| Net Income | $-1.6M | - | - |
| Eps Basic | -0.01 | - | - |
| Eps Diluted | -0.01 | - | - |
| Total Assets | $1.4B | - | - |
| Shareholders Equity | $466.1M | - | - |
| Operating Cash Flow | $179.6M | - | - |
| Capital Expenditures | $22.7M | - | - |